Psoriasis: Treatment and Pathogenesis
Psoriasis: Treatment and Pathogenesis is a research topic within Immunology. Science Explorer counts 28k research works in it since 1950. 17.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the reciprocal developmental pathways for the generation of pathogenic effector TH17 cells and regulatory T cells, particularly in the context of autoimmune inflammation, interleukin-23, psoriasis, and the role of cytokines such as TGF-ß. It also explores the differentiation, cytokine profile, and function of human interleukin 17–producing helper T cells.
- IL-17
- TH17 Cells
- Interleukin-23
- Autoimmune Inflammation
- Psoriasis
- TGF-ß
- Regulatory T Cells
- Inflammatory Cytokines
- Pathogenic Effector Cells
- Immune System
- Research works
- 28k fractional, since 1950
- In the world top 10%
- 5k per year above
- Top-10% rate
- 17.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +41% the tick is no change
Which countries lead Psoriasis: Treatment and Pathogenesis research?
By volume, the United States and China publish the most (1.2k and 1.2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.2k works
- 2 China 1.2k works
- 3 India 375 works
- 4 Italy 357 works
- 5 United Kingdom 334 works
- 6 Germany 325 works
- 7 Spain 262 works
- 8 Japan 236 works
- 9 France 215 works
- 10 Canada 208 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Psoriasis: Treatment and Pathogenesis research?
By volume in 2022–2025, Icahn School of Medicine at Mount Sinai publishes the most Psoriasis: Treatment and Pathogenesis research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and University of Naples Federico II.
By volume, 2022–2025
- 1 Icahn School of Medicine at Mount SinaiUnited States 44 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 28 works
- 3 University of Naples Federico IIItaly 28 works
- 4 University of California, San FranciscoUnited States 27 works
- 5 University of TorontoCanada 24 works
- 6 Brigham and Women's HospitalUnited States 23 works
- 7 Central South UniversityChina 23 works
- 8 Harvard UniversityUnited States 22 works
- 9 King's College LondonUnited Kingdom 21 works
- 10 Wake Forest UniversityUnited States 20 works
Who are the leading researchers in Psoriasis: Treatment and Pathogenesis?
The most-cited researchers publishing on Psoriasis: Treatment and Pathogenesis include Luigi Naldi and Mohammad Ali Sahraian.
- 1 Luigi Naldi Italy 4.7k citations
- 2 Mohammad Ali Sahraian Iran 4.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Psoriasis: Treatment and Pathogenesis research done?
The largest centres of Psoriasis: Treatment and Pathogenesis research in 2022–2025 are Beijing (China), Shanghai (China), New York (United States) and London (United Kingdom).
Where is the best place to study Psoriasis: Treatment and Pathogenesis?
Among universities, judged by research, University of Naples Federico II, Icahn School of Medicine at Mount Sinai and University of Lübeck score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Naples Federico IIItaly | 68.9 | 39.9% | 6.7× | 28 | +29.7% |
| 2 | Icahn School of Medicine at Mount SinaiUnited States | 67.7 | 15.8% | 13.4× | 44 | +84.1% |
| 3 | University of LübeckGermany | 66.4 | 26.4% | 16.2× | 16 | +97.5% |
| 4 | Shanghai University of Traditional Chinese MedicineChina | 60.3 | 25.8% | 10.3× | 14 | +106.8% |
| 5 | Humanitas UniversityItaly | 58.7 | 27.5% | 16.6× | 9 | — |
| 6 | Wroclaw Medical UniversityPoland | 54.1 | 19.8% | 10.6× | 11 | +98.7% |
| 7 | Medical University of BiałystokPoland | 52.7 | 16.1% | 19.5× | 12 | +110.6% |
| 8 | Wake Forest UniversityUnited States | 52.3 | 11.8% | 11.9× | 20 | +54.5% |
| 9 | University of California, San FranciscoUnited States | 51.7 | 14.0% | 6.3× | 27 | +95.1% |
| 10 | Medical University of LodzPoland | 50.3 | 16.3% | 14.6× | 15 | +18.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Psoriasis: Treatment and Pathogenesis research growing?
Output in 2018–2022 was 41% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Psoriasis: Treatment and Pathogenesis.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.